{"id":"https://openalex.org/W4399123786","doi":"https://doi.org/10.1200/jco.2024.42.16_suppl.581","title":"Patient-derived tumor cell clusters (PTC) guiding-neoadjuvant therapy of HER2-positive breast cancer: A prospective randomized phase II clinical trial.","display_name":"Patient-derived tumor cell clusters (PTC) guiding-neoadjuvant therapy of HER2-positive breast cancer: A prospective randomized phase II clinical trial.","publication_year":2024,"publication_date":"2024-05-29","ids":{"openalex":"https://openalex.org/W4399123786","doi":"https://doi.org/10.1200/jco.2024.42.16_suppl.581"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2024.42.16_suppl.581","doi":"https://doi.org/10.1200/jco.2024.42.16_suppl.581","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1200/jco.2024.42.16_suppl.581","pdf_url":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2024.42.16_suppl.581","source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2024.42.16_suppl.581","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101863579","display_name":"Xingfei Yu","orcid":"https://orcid.org/0000-0002-6032-167X","observed_orcids":["https://orcid.org/0000-0002-6032-167X"]},"institutions":[{"id":"https://openalex.org/I4210098734","display_name":"Zhejiang Cancer Hospital","ror":"https://ror.org/0144s0951","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210098734"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xingfei Yu","raw_affiliation_strings":["Zhejiang Cancer Hospital, Hangzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Zhejiang Cancer Hospital, Hangzhou, China","institution_ids":["https://openalex.org/I4210098734"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100595989","display_name":"Xiaofan Wu","orcid":"https://orcid.org/0009-0009-5095-0446","observed_orcids":["https://orcid.org/0009-0009-5095-0446","https://orcid.org/0009-0003-8043-5548"]},"institutions":[{"id":"https://openalex.org/I4210098734","display_name":"Zhejiang Cancer Hospital","ror":"https://ror.org/0144s0951","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210098734"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xiaofan Wu","raw_affiliation_strings":["Zhejiang Cancer Hospital, Hangzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Zhejiang Cancer Hospital, Hangzhou, China","institution_ids":["https://openalex.org/I4210098734"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100337669","display_name":"Chen Wang","orcid":"https://orcid.org/0000-0003-2638-3081","observed_orcids":["https://orcid.org/0000-0003-2638-3081"]},"institutions":[{"id":"https://openalex.org/I4210098734","display_name":"Zhejiang Cancer Hospital","ror":"https://ror.org/0144s0951","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210098734"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Chen Wang","raw_affiliation_strings":["Zhejiang Cancer Hospital, Hangzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Zhejiang Cancer Hospital, Hangzhou, China","institution_ids":["https://openalex.org/I4210098734"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103564758","display_name":"Weiliang Feng","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210098734","display_name":"Zhejiang Cancer Hospital","ror":"https://ror.org/0144s0951","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210098734"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Weiliang Feng","raw_affiliation_strings":["Zhejiang Cancer Hospital, Hangzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Zhejiang Cancer Hospital, Hangzhou, China","institution_ids":["https://openalex.org/I4210098734"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102853823","display_name":"Yabing Zheng","orcid":"https://orcid.org/0000-0002-4835-4399","observed_orcids":["https://orcid.org/0000-0002-4835-4399"]},"institutions":[{"id":"https://openalex.org/I4210098734","display_name":"Zhejiang Cancer Hospital","ror":"https://ror.org/0144s0951","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210098734"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yabing Zheng","raw_affiliation_strings":["Zhejiang Cancer Hospital, Hangzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Zhejiang Cancer Hospital, Hangzhou, China","institution_ids":["https://openalex.org/I4210098734"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5101832106","display_name":"Hongjian Yang","orcid":"https://orcid.org/0000-0003-1583-2814","observed_orcids":["https://orcid.org/0000-0003-1583-2814"]},"institutions":[{"id":"https://openalex.org/I4210098734","display_name":"Zhejiang Cancer Hospital","ror":"https://ror.org/0144s0951","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210098734"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Hongjian Yang","raw_affiliation_strings":["Zhejiang Cancer Hospital, Hangzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Zhejiang Cancer Hospital, Hangzhou, China","institution_ids":["https://openalex.org/I4210098734"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210098734"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"42","issue":"16_suppl","first_page":"581","last_page":"581"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.5791000127792358,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.5791000127792358,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.39399999380111694,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11134","display_name":"Breast Lesions and Carcinomas","score":0.004000000189989805,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.9959999918937683},{"id":"https://openalex.org/keywords/neoadjuvant-therapy","display_name":"neoadjuvant therapy","score":0.9929999709129333},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.5690000057220459},{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":0.7459999918937683},{"id":"https://openalex.org/keywords/pertuzumab","display_name":"pertuzumab","score":0.9959999918937683},{"id":"https://openalex.org/keywords/pyrotinib","display_name":"pyrotinib","score":0.9380000233650208},{"id":"https://openalex.org/keywords/docetaxel","display_name":"docetaxel","score":0.859000027179718},{"id":"https://openalex.org/keywords/carboplatin","display_name":"carboplatin","score":0.6570000052452087},{"id":"https://openalex.org/keywords/cyclophosphamide","display_name":"cyclophosphamide","score":0.7390000224113464},{"id":"https://openalex.org/keywords/epirubicin","display_name":"epirubicin","score":0.9340000152587891},{"id":"https://openalex.org/keywords/pathological-complete-response","display_name":"pathological complete response","score":0.9049999713897705},{"id":"https://openalex.org/keywords/treatment-selection","display_name":"treatment selection","score":0.3190000057220459},{"id":"https://openalex.org/keywords/early-breast-cancer","display_name":"early breast cancer","score":0.734000027179718},{"id":"https://openalex.org/keywords/disease-free-survival","display_name":"disease-free survival","score":0.8090000152587891},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.7549999952316284},{"id":"https://openalex.org/keywords/objective-response-rate","display_name":"objective response rate","score":0.6370000243186951}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9235304594039917},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6714240312576294},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6022052764892578},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5262119770050049},{"id":"https://openalex.org/C2778292576","wikidata":"https://www.wikidata.org/wiki/Q6991934","display_name":"Neoadjuvant therapy","level":4,"score":0.48087742924690247},{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.4583214819431305},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4458428919315338},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.41125035285949707}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2024.42.16_suppl.581","doi":"https://doi.org/10.1200/jco.2024.42.16_suppl.581","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1200/jco.2024.42.16_suppl.581","pdf_url":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2024.42.16_suppl.581","source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1200/jco.2024.42.16_suppl.581","doi":"https://doi.org/10.1200/jco.2024.42.16_suppl.581","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1200/jco.2024.42.16_suppl.581","pdf_url":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2024.42.16_suppl.581","source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.8600000143051147,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4399123786.pdf","grobid_xml":"https://content.openalex.org/works/W4399123786.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2342209702","https://openalex.org/W2945034398","https://openalex.org/W2001196910","https://openalex.org/W3024330839","https://openalex.org/W2468646525","https://openalex.org/W4383618614","https://openalex.org/W2095633632","https://openalex.org/W2221528691","https://openalex.org/W2409773829","https://openalex.org/W2107622303"],"abstract_inverted_index":{"581":[0],"Background:":[1],"In":[2,320],"a":[3,88,265,287],"previous":[4],"study,":[5,210],"the":[6,43,74,84,96,107,110,117,122,213,218,233,269,273,283,304,326,332],"patient-derived":[7],"tumor-like":[8],"cell":[9],"clusters":[10],"(PTC)":[11],"were":[12,206],"confirmed":[13],"to":[14,35,72],"be":[15],"an":[16,78],"accurate":[17],"medicine":[18],"effect-predicting":[19],"model":[20],"in":[21,48,95,161,208,212,217,232,310,340],"vitro":[22],"for":[23,69],"clinical":[24],"practice":[25],"(1).":[26],"We":[27,61],"designed":[28],"this":[29,38,209,321],"prospective":[30],"randomized":[31],"phase":[32],"II":[33],"trial":[34,351],"research":[36],"if":[37],"PTC-guiding":[39,75,240,274,305,327],"strategy":[40,306],"could":[41,330],"improve":[42,331],"effect":[44],"of":[45,83,175,226,272,282],"neoadjuvant":[46,70,328],"therapy":[47,71,329],"human":[49],"epidermal":[50],"growth":[51],"factor":[52],"receptor":[53],"2":[54],"(HER2)":[55],"positive":[56],"breast":[57,65,342],"cancer":[58,66],"(NCT05103293).":[59],"Methods:":[60],"enrolled":[62,207],"HER2-positive":[63,341],"early":[64],"patients":[67,94,205],"planning":[68],"accept":[73],"regimen":[76,108],"as":[77,87,116],"experimental":[79,97,214,222],"group":[80,90,98,223,235,276,285],"or":[81],"regimens":[82,125],"physician's":[85],"choice":[86],"control":[89,219,234,284],"randomly.":[91],"All":[92],"eligible":[93],"would":[99],"receive":[100],"medicine-sensitive":[101],"testing":[102],"by":[103],"PTC":[104,112],"then":[105],"accepted":[106],"with":[109,128,133,141,148],"highest":[111],"killing":[113],"rate":[114,193,257],"(30%":[115],"lowest":[118],"cut-off":[119],"value)":[120],"from":[121],"three":[123],"candidate":[124],"(Cyclophosphamide":[126],"combined":[127,132],"epirubicin":[129],"--":[130],"Docetaxel":[131,138,147],"trastuzumab":[134,142,149],"and":[135,139,143,146,150,177,198,215,254,312,338],"pertuzumab,":[136,144],"EC-THP,":[137],"carboplatin":[140],"TCbHP":[145],"pyrotinib,":[151],"THPy).":[152],"The":[153,182,221,239,293],"primary":[154],"endpoint":[155],"is":[156],"pathological":[157],"complete":[158],"response":[159,192,256],"(pCR)":[160],"two":[162,294],"groups":[163,295],"using":[164],"superiority":[165,178],"odd":[166],"ratio":[167],"Fisher's":[168],"exact":[169],"test":[170],"(one-sided":[171],"alpha":[172],"=0.05,":[173],"power":[174],"80%,":[176],"margin":[179],"at":[180],"0.1).":[181],"secondary":[183],"endpoints":[184],"are":[185],"Miller-Payne":[186],"(MP)":[187],"grade":[188],"4~5":[189,246],"proportion,":[190],"objective":[191,255],"(ORR),":[194],"disease-free":[195,270],"survival":[196,200,271,299],"(DFS),":[197],"overall":[199,298],"(OS).":[201],"Results:":[202],"Finally,":[203],"86":[204],"44":[211],"42":[216],"groups.":[220],"had":[224,296],"65.9%":[225],"pCR,":[227,335],"significantly":[228,307],"higher":[229,279],"than":[230,280],"42.9%":[231],"(Hazard":[236],"ratio=0.388,":[237],"P=0.033).":[238],"treatment":[241,275],"also":[242],"considerably":[243],"increased":[244],"MP":[245,336],"proportion":[247],"(79.5%":[248],"vs.":[249],"59.4%,":[250],"Hazard":[251,261],"ratio=0.283,":[252],"P=0.009)":[253],"(90.9%":[258],"vs":[259],"71.4%,":[260],"ratio=0.250,":[262],"P=0.027).":[263],"After":[264],"two-year":[266],"medium":[267],"follow-up,":[268],"was":[277],"84.1%":[278],"71.4%":[281],"without":[286],"significant":[288],"difference":[289],"(Log":[290,300],"Rank,":[291,301],"P=0.106).":[292],"similar":[297],"P=0.958).":[302],"Furthermore,":[303],"impacted":[308],"pCR":[309],"univariate":[311],"multivariate":[313],"regression":[314],"analyses":[315],"but":[316],"not":[317],"survival.":[318],"Conclusions:":[319],"trial,":[322],"we":[323],"concluded":[324],"that":[325],"effect,":[333],"including":[334],"score,":[337],"ORR":[339],"cancer.":[343],"1.":[344],"Yin":[345],"et":[346],"al.,":[347],"Sci.Transl.":[348],"2020.":[349],"Clinical":[350],"information:":[352],"NCT05103293":[353],".":[354]},"counts_by_year":[],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2025-10-10T00:00:00"}